AMI ASSET MANAGEMENT CORP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMI ASSET MANAGEMENT CORP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,306,000
+0.6%
514,101
+2.6%
0.27%
-3.6%
Q1 2021$5,272,000
-4.7%
501,172
+40.2%
0.28%
+0.7%
Q4 2020$5,532,000
-38.2%
357,349
-41.7%
0.27%
-39.8%
Q3 2020$8,949,000612,9620.46%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 999,275$37,403,00055.08%
New Leaf Venture Partners, L.L.C. 126,687$4,742,0002.31%
Cormorant Asset Management, LP 385,000$14,411,0002.22%
SECTORAL ASSET MANAGEMENT INC 529,920$19,835,0000.89%
PFM Health Sciences, LP 850,337$31,828,0000.74%
Partner Investment Management, L.P. 16,399$614,0000.25%
Tekla Capital Management LLC 137,766$5,157,0000.24%
Candriam S.C.A. 298,000$11,154,0000.23%
Eventide Asset Management 30,000$1,123,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 81,047$3,034,0000.12%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders